Singulus Technologies (SNG) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 was €16.4 million, down from €20.6 million year-over-year.

• EBIT remained slightly positive at €0.5 million, compared to €0.6 million in Q1 2024.

• Incoming orders dropped sharply to €6.4 million from €33.2 million year-over-year.

• Order backlog as of March 31, 2025, was €67.4 million, slightly lower than €71.6 million a year earlier.

• Gross margin improved to 34.6% from 29.4% year-over-year.

Outlook and guidance

• Management expects revenue growth and improved earnings for 2025, assuming stabilization in global economic conditions and successful order intake.

• All three segments—Solar, Semiconductor, and Life Science—are expected to contribute positively to consolidated earnings.

• The company is monitoring geopolitical risks and trade conflicts, which could impact supply chains and order intake.

Segment performance

• Semiconductor: Focus on high-precision manufacturing for MRAM, thin-film heads, micro-LEDs, and sensors; strong demand from sensor manufacturers.

• Life Science: Expanding wet-chemical and coating technologies for medical, cosmetics, and automotive applications; regulatory compliance and new modules developed.

• Solar: Investments in HJT and tandem solar cell technologies; turnkey solutions for industrial production; several new orders for coating technologies.

• New business areas: Initial orders received in hydrogen technology (bipolar plates for electrolyzers) and next-generation batteries (solid-state); leveraging existing coating expertise.